Form D · Biotechnology
SLAM BioTherapeutics, Inc.
Westlake Village, CA · CIK 0001983523
Offering snapshot reported Dec 29, 2025 · SEC filing
- Reported sold
- $1M Offering amount: $4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 19, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2025 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 3, 2025 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Nov 13, 2023 | Initial | $7,705,000 | No comparison | 38 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568154
Source: Form D, filed Dec 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Hagler | Director |
| Richard Heinick | Director, Executive |
| Steve Pazol | Director |
| Steve Potts | Director, Executive |
| Theodore Schwartz | Director |
| Ted Schwartz | Director |
| David Vennettilli | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2945 Townsgate Rd., Suite 200
Westlake Village, CA, 91361
Westlake Village, CA, 91361